SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-23-001001
Filing Date
2023-12-27
Accepted
2023-12-27 09:02:53
Documents
2
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1106
2 frtxdelistreason.txt EX-99.25 1145
  Complete submission text file 0001354457-23-001001.txt   4248
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Subject) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 000-21088
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE